Sign up here to receive “The US in brief” as a newsletter, each weekday, in your inbox.
Insurance data reveals dramatic regional differences in Ozempic and Mounjaro usage, with obesity-heavy states prescribing GLP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback